INR 536.9
(-1.73%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 121.64 Million | -259.92 Million | 8.35 Million | -48.58 Million | -5.84 Million | -57.19 Million |
Net Income | 109.72 Million | 31.89 Million | 54.6 Million | 44.16 Million | 30.01 Million | 31.01 Million |
Depreciation & Amortization | 7.81 Million | 7.73 Million | 6.14 Million | 4.6 Million | 1.06 Million | 1.12 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -12.96 Million | -294.88 Million | -58.98 Million | -96.41 Million | -37.69 Million | -95.23 Million |
Other non-cash items | 222.06 Million | 233.78 Million | 102.59 Million | 5.5 Million | 102.88 Million | 88.22 Million |
Investing Cash Flow | -56.09 Million | -33.88 Million | -39.98 Million | -17.81 Million | -10.52 Million | 5.04 Million |
Investments in PPE | -22.23 Million | -519 Thousand | -17.38 Million | -10.08 Million | -2.15 Million | -436 Thousand |
Acquisitions | 223 Thousand | - | 42 Thousand | 245 Thousand | - | 1 Million |
Investment purchases | -35.02 Million | -33.36 Million | -22.64 Million | -7.98 Million | -8.37 Million | - |
Sales/Maturities of investments | - | - | - | - | - | 4.48 Million |
Other Investing Activities | 938 Thousand | -1.00 | - | - | - | - |
Financing Cash Flow | -54.15 Million | 281.68 Million | 45.34 Million | 67.3 Million | 16.91 Million | 33.58 Million |
Debt repayment | -54.15 Million | -281.68 Million | -45.34 Million | -67.3 Million | -16.91 Million | -33.58 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | 67.17 Million |
Accounts receivables | -318.8 Million | -188.35 Million | -76.1 Million | 17.06 Million | -77.04 Million | -70.8 Million |
Accounts payables | 102.88 Million | -159.92 Million | 100.03 Million | 59.06 Million | 22.73 Million | 9.33 Million |
Inventory | 26.55 Million | 125.29 Million | -107.65 Million | -73.35 Million | -45.66 Million | -18.6 Million |
Other working capital | 176.39 Million | -71.91 Million | 24.74 Million | -99.18 Million | 62.29 Million | -15.15 Million |
Cash at beginning of period | 55.7 Million | 34.03 Million | 25.54 Million | 1.84 Million | 1.3 Million | 25.19 Million |
Cash at end of period | 102.12 Million | 55.7 Million | 34.03 Million | 25.54 Million | 1.84 Million | 1.3 Million |
Capital Expenditure | -22.23 Million | -519 Thousand | -17.38 Million | -10.08 Million | -2.15 Million | -436 Thousand |
Effect of forex changes on cash | - | -1.00 | -5.21 Million | 22.8 Million | - | -5.33 Million |
Net cash flow / Change in cash | 46.41 Million | 21.67 Million | 8.49 Million | 23.7 Million | 540 Thousand | -23.89 Million |
Free Cash Flow | 99.41 Million | -260.44 Million | -9.03 Million | -58.66 Million | -7.99 Million | -57.63 Million |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 109.72 Million | 29.46 Million | 14.84 Million | 8.18 Million | 31.89 Million | 16.12 Million |
Depreciation & Amortization | 7.81 Million | 1.99 Million | 1.85 Million | 1.91 Million | 7.73 Million | 1.99 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -12.96 Million | - | - | - | -294.88 Million | - |
Other non-cash items | 222.06 Million | -1.99 Million | -1.85 Million | -1.91 Million | 233.78 Million | -1.99 Million |
Investing Cash Flow | -56.09 Million | - | - | - | -33.88 Million | - |
Investments in PPE | -22.23 Million | - | - | - | -519 Thousand | - |
Acquisitions | 223 Thousand | - | - | - | - | - |
Investment purchases | -35.02 Million | - | - | - | -33.36 Million | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 938 Thousand | - | - | - | -1.00 | - |
Financing Cash Flow | -54.15 Million | - | - | - | 281.68 Million | - |
Debt repayment | -54.15 Million | - | - | - | -281.68 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | -318.8 Million | - | - | - | -188.35 Million | - |
Accounts payables | 102.88 Million | - | - | - | -159.92 Million | - |
Inventory | 26.55 Million | - | - | - | 125.29 Million | - |
Other working capital | 176.39 Million | - | - | - | -71.91 Million | - |
Cash at beginning of period | 55.7 Million | 52.87 Million | 38.03 Million | 55.7 Million | 34.03 Million | 39.58 Million |
Cash at end of period | 102.12 Million | 29.46 Million | 52.87 Million | 8.18 Million | 55.7 Million | 55.7 Million |
Capital Expenditure | -22.23 Million | - | - | - | -519 Thousand | - |
Effect of forex changes on cash | - | - | - | - | -1.00 | - |
Net cash flow / Change in cash | 46.41 Million | -23.41 Million | 14.84 Million | -47.52 Million | 21.67 Million | 16.12 Million |
Free Cash Flow | 99.41 Million | 29.46 Million | 14.84 Million | 8.18 Million | -260.44 Million | 16.12 Million |
THEMISMED
BNL
6549
WKPPF
SEB
IMMX